ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

ClinicalTrials.gov ID: NCT01776424

Public ClinicalTrials.gov record NCT01776424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS).

Study identification

NCT ID
NCT01776424
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
27,395 participants

Conditions and interventions

Interventions

  • Aspirin Drug
  • Aspirin placebo Drug
  • Pantoprazole Drug
  • Pantoprazole placebo Drug
  • Rivaroxaban (Xarelto, BAY59-7939) Drug
  • Rivaroxaban placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 27, 2013
Primary completion
Jul 20, 2017
Completion
Jun 14, 2021
Last update posted
Nov 27, 2022

2013 – 2021

United States locations

U.S. sites
53
U.S. states
21
U.S. cities
52
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294
Not listed Mobile Alabama 36608
Not listed Anaheim California 92801
Not listed Laguna Hills California 92653
Not listed Northridge California 91324
Not listed Palo Alto California 94304-1207
Not listed Santa Rosa California 95494
Not listed Sylmar California 91342
Not listed Torrance California 90502-2004
Not listed Norwalk Connecticut 06851
Not listed Stamford Connecticut 06905
Not listed Trumbull Connecticut 06611
Not listed Atlantis Florida 33462
Not listed Clearwater Florida 33756
Not listed Coral Springs Florida 33065
Not listed Jacksonville Beach Florida 32250
Not listed Largo Florida 33770
Not listed New Port Richey Florida 34653
Not listed Safety Harbor Florida 34695
Not listed Sarasota Florida 34239
Not listed Meridian Idaho 83716
Not listed Arlington Heights Illinois 60005
Not listed Hazel Crest Illinois 60429
Not listed Davenport Iowa 52803
Not listed West Des Moines Iowa 50266
Not listed Crestview Hills Kentucky 41017-5460
Not listed Baltimore Maryland 21215
Not listed Haverhill Massachusetts 01830
Not listed Alpena Michigan 49707
Not listed Jackson Michigan 49201
Not listed St Louis Missouri 63136
Not listed Kalispell Montana 59901
Not listed New Brunswick New Jersey 08901
Not listed Cortlandt Manor New York 10567
Not listed Kingston New York 12401
Not listed Saratoga Springs New York 12866
Not listed Durham North Carolina 27713
Not listed Pinehurst North Carolina 28374
Not listed Elyria Ohio 44035
Not listed Sandusky Ohio 44870
Not listed Toledo Ohio 43606
Not listed Doylestown Pennsylvania 18901
Not listed Langhorne Pennsylvania 19047
Not listed Yardley Pennsylvania 19067
Not listed Sioux Falls South Dakota 57108
Not listed Dallas Texas 75216-7167
Not listed Houston Texas 77030-4298
Not listed Houston Texas 77030
Not listed San Antonio Texas 78229
Not listed Bellevue Washington 98004-4623
Not listed Puyallup Washington 98372
Not listed Seattle Washington 98195
Not listed Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 512 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01776424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 27, 2022 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01776424 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →